{{Rsnum
|rsid=12423791
|Gene=IGF1
|Chromosome=12
|position=102465050
|Orientation=plus
|GMAF=0.08861
|Gene_s=IGF1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 5.1 | 43.8 | 51.1
| JPT | 5.3 | 32.7 | 61.9
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 5.1 | 43.8 | 51.1
| CHD | 9.2 | 47.7 | 43.1
| GIH | 1.0 | 15.8 | 83.2
| LWK | 0.0 | 0.0 | 0.0
| MEX | 3.4 | 22.4 | 74.1
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22509095
|Title=Association of insulin-like growth factor-1 polymorphisms with high myopia in the Chinese population
|OA=1
}}

{{PMID|18163429|OA=1
}} Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.

{{PMID Auto
|PMID=23530598
|Title=Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis
|OA=1
}}

{{on chip | Affy GenomeWide 6}}